Brand & Strategic Alliances Manager
MSD
Total years of experience :16 years, 1 Months
Managed the strategic alliances platform of $31M P&L including two major business
development projects:
1- The co-marketing agreement with SPIMACO (including clones for Januvai®, Singulair® & Arcoxia®) ensuring full alignment of marketing strategies between the 2 parties (MSD & SPIMACO).
2- Third-Party Promotion (TPP) agreement with another local partner (TAMER), including
but not limited to:
- Strategy and Compliance measures.
- Success KPIs and Alignment calendar.
- Financial and profitability analysis.
- Marketing plans & resources, mainly for CVS products (Cozaar® Franchise, Zocor® &
Renitec® Franchise), CNS product (Remeron®), Urology product (Proscar®) &
Derma product (Elocom®).
- Team guiding & marketing trainings including field double visits to identify how the
message is delivered and market perception towards promotional campaigns.
- Business reviews with partners.
- Resolving operational conflicts and internal alignment.
Managed $17M P&L and drove respiratory franchise strategy.
1- Managed profitable growth of respiratory portfolio including Singulair® (Leukotriene
Receptor Antagonist) & Nasonex® (Intranasal Steroid), and ensured market leadership position for Singulair® pediatric forms & Nasonex®.
2- Established close relationships with global and regional brand leads tailoring their strategies to align with local market dynamics in order to meet company objectives.
3- Managed to train the field force in areas related to promotional claims, positioning,
handling of promotional materials, defining the relevant strategies and tactics.
4- Managed vendors and negotiated cost reductions to optimize promotional expenses.
5- Utilization of innovative digital marketing technology in collaboration with e-marketing
team to optimize reach to different customer types & maximize share of voice.
6- Established short & long-term strategic platform for the portfolio as well as upcoming portfolio fits (New Launches - Business Development Opportunities).
7- Monitored IMS & Market analytics addressing future growth opportunities and
performance gaps, and aligning the team on required action plans.
8- Developed a network of KOLs ensuring high level of brands advocacy.
9- Ensured close collaboration with e-Marketing and Learning & Development teams.
1- Lead Ezetrol® (Cholesterol Absorption Inhibitor) & Inegy® (FDC of Ezetrol+Simvastatin) Team in Western & Southern Regions (Private, Institution & MOH
sectors).
2- Efficiently coached, trained and guided my team members to develop their skills to achieve company objectives through:
i. Hiring right talents matching team requirements.
ii. Team development planning, considering needed behavioural and technical skills.
iii. Dynamic coaching during field double visits and office meeting times.
iv. Performance management planning considering setting objective KPIs.
v. Talent management.
3- Private Sector:
i. Tripled the market share of Ezetrol franchise on YTD basis from 3.3% (December 2010) to 9.7% (December 2014), exceeding allocated targets year over year.
4- Institution Sector:
i. Managed the inclusion of Ezetrol in the formulary of Armed Forces Hospital Southern Region, Najran Military Hospital, Islamic University and Taiba University Hospitals (Madina).
ii. Retention of Ezetrol in the formulary of other West institutions like KFAFH, NWAFH & KFSH ensuring sustainable profitable growth.
5- MOH Sector:
i. Managed the inclusion of Ezetrol in the formulary of Makkah Medical Supply (Including Al Nour Specialist Hospital), King Abdullah Medical City, King Abdulaziz Hospital & Oncology Center (Jeddah) & Tabuk Medical Supply, together with inclusion of Inegy 10/40 in Assir Central Hospital.
ii. Retention of Ezetrol in the formulary of other West MOH accounts ensuring sustainable profitable growth.
Launch team of Januvia
Launch team of Singulair Granules
Launching Tavanic in National Cancer Institute
Bachelor of pharmaceutical sciences